AVBP (STOCKS)
ArriVent BioPharma, Inc. Common Stock
$21.620000
+0.540000 (+2.56%)
Prev close: $21.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Zheng Bin Yao
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $892.92M
- Employees
- 52
- P/E (TTM)
- -5.10
- P/B (TTM)
- 2.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.83 | $-0.81 | -0.0249 | -3.09% |
|
Jun 2025 (Q2)
|
$-0.90 | $-0.72 | -0.1822 | -25.38% |
|
Mar 2025 (Q1)
|
$-1.90 | $-0.68 | -1.2227 | -180.53% |
|
Dec 2024 (Q4)
|
$-0.61 | $-0.79 | +0.1825 | +23.03% |
Financial Statements
| Assets | $326.56M |
| Current Assets | $321.22M |
| Noncurrent Assets | $5.34M |
| Liabilities | $21.56M |
| Current Liabilities | $21.56M |
| Accounts Payable | $5.93M |
| Wages | $4.39M |
| Other Current Liabilities | $11.24M |
| Noncurrent Liabilities | $0.00 |
| Equity | $305.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $305.00M |
| Liabilities And Equity | $326.56M |